Predictive Oncology Inc. (POAI)
NASDAQ: POAI · Real-Time Price · USD
9.54
-1.46 (-13.32%)
At close: Oct 17, 2025, 4:00 PM EDT
9.55
+0.02 (0.16%)
After-hours: Oct 17, 2025, 7:59 PM EDT
Predictive Oncology Market Cap
Predictive Oncology has a market cap or net worth of $7.27 million as of October 17, 2025. Its market cap has increased by 39.67% in one year.
Market Cap
7.27M
Enterprise Value
8.88M
1-Year Change
39.67%
Ranking
Category
Stock Price
$9.54
Market Cap Chart
Since April 9, 2010, Predictive Oncology's market cap has increased from $1.69M to $7.27M, an increase of 330.85%. That is a compound annual growth rate of 9.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2025 | 8.39M | 53.41% |
| Dec 31, 2024 | 5.47M | -59.10% |
| Dec 29, 2023 | 13.37M | -44.64% |
| Dec 30, 2022 | 24.15M | -61.32% |
| Dec 31, 2021 | 62.42M | 382.16% |
| Dec 31, 2020 | 12.95M | 26.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 742.04B |
| Johnson & Johnson | 460.40B |
| AbbVie | 399.63B |
| UnitedHealth Group | 327.08B |
| AstraZeneca | 262.65B |
| Novartis AG | 252.43B |
| Novo Nordisk | 251.88B |
| Abbott Laboratories | 225.30B |